Hosted on MSN2d
New Hope for Metastatic Colorectal Cancer Patients: A Targeted Approach With a Drug Called Encorafenib Gets FDA Approval
A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...
MedPage Today5d
Doc Suspected in Mass Killing; Vaccine Injury Claims Spike; Iowa Has First H5N1 Case
Iowa has its first confirmed case of H5N1 bird flu in a poultry farm worker, the state's public health department announced.
PMLiVE5d
Pfizer’s Braftovi regimen receives FDA accelerated approval to treat colorectal cancer
Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...
Pfizer’s colorectal cancer combo therapy gains accelerated approval from FDA
The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.
The Pharma Letter5d
FDA approves new use for Pfizer’s Braftovi combo
US pharma giant Pfizer on Friday revealed that the US Food and Drug Administration (FDA) has approved its Braftovi ...
Pharmabiz6d
Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer
Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...